Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

165.98
+1.490.91%
Post-market: 166.110.1300+0.08%19:53 EDT
Volume:3.18M
Turnover:527.99M
Market Cap:257.43B
PE:24.85
High:167.25
Open:164.04
Low:163.96
Close:164.49
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.84
T/O Rate:0.21%
Dividend:3.23
Dividend Rate:1.95%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.12
PE(LYR):25.38

Loading ...

AstraZeneca Shuts Down China NASH Registry: What It Means for AZN Investors

TIPRANKS
·
Jul 30

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 30

Deutsche Bank Keeps Their Sell Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 28

AstraZeneca Upbeat Internal Pipeline Can Drive Growth Beyond 2030

Dow Jones
·
Jul 28

AstraZeneca (AZN) Gets a Buy from Barclays

TIPRANKS
·
Jul 28

Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 28

AstraZeneca Beats Q2 Core Earnings Forecast, Reaffirms $80 Billion Revenue Goal for 2030

Deep News
·
Jul 28

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Top Midday Stories: Nvidia Enters Into $500 Billion Partnership With SK Group; AstraZeneca Earnings Top Estimates

MT Newswires Live
·
Jul 27

AstraZeneca Posts 6% Revenue Growth in First Half, Maintains Full-Year Forecast

Deep News
·
Jul 27

AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright

TIPRANKS
·
Jul 27

Omeros up 11% to $10.89 after AstraZeneca study failure

TIPRANKS
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Oil Prices Fall

MT Newswires Live
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 27

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27

Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says

Dow Jones
·
Jul 27

Europe, Japan are Falling Behind on Pharma Innovation, AstraZeneca CEO Says

Dow Jones
·
Jul 27